Published in Open Virol J on July 04, 2011
On the binding affinity of macromolecular interactions: daring to ask why proteins interact. J R Soc Interface (2012) 1.16
Therapy of human papillomavirus-related disease. Vaccine (2012) 1.11
Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. Antimicrob Agents Chemother (2012) 1.08
Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest. Cell Cycle (2013) 1.04
A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors. Cancer Gene Ther (2012) 0.97
The E1 protein of human papillomavirus type 16 is dispensable for maintenance replication of the viral genome. J Virol (2012) 0.95
Modulation of apoptotic pathways by human papillomaviruses (HPV): mechanisms and implications for therapy. Viruses (2012) 0.87
Small molecule inhibitors of the HPV16-E6 interaction with caspase 8. Bioorg Med Chem Lett (2012) 0.87
The HPV E2-Host Protein-Protein Interactions: A Complex Hijacking of the Cellular Network. Open Virol J (2012) 0.86
Discovering new medicines targeting helicases: challenges and recent progress. J Biomol Screen (2013) 0.85
Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer. Viruses (2015) 0.79
Targeting human papillomavirus genome replication for antiviral drug discovery. Antivir Ther (2013) 0.78
Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma. Oral Oncol (2014) 0.77
New Frontiers in Druggability. J Med Chem (2015) 0.77
Sequence variation in the E2-binding domain of HPV16 and biological function evaluation in Tunisian cervical cancers. Biomed Res Int (2014) 0.75
CCHCR1 interacts specifically with the E2 protein of human papillomavirus type 16 on a surface overlapping BRD4 binding. PLoS One (2014) 0.75
Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV(+) cells. Cell Death Dis (2016) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Classification of papillomaviruses. Virology (2004) 14.16
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med (2011) 11.09
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J (1989) 6.60
Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science (2000) 6.44
Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov (2006) 6.39
Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science (1990) 4.92
Mechanism of DNA translocation in a replicative hexameric helicase. Nature (2006) 4.91
Activation of BPV-1 replication in vitro by the transcription factor E2. Nature (1991) 4.51
Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science (1992) 4.49
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer (2003) 4.40
Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell (2004) 4.38
Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One (2008) 4.24
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res (1996) 4.14
Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol (1993) 4.04
Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer (2004) 4.04
The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer (2007) 3.99
Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95
The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J (1987) 3.86
Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci U S A (1992) 3.58
The papillomavirus life cycle. J Clin Virol (2005) 3.41
Comparison of a structural and a functional epitope. J Mol Biol (1993) 3.12
Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol (1993) 2.91
Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol (2000) 2.79
Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin. Proc Natl Acad Sci U S A (1993) 2.74
Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev (1994) 2.72
The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro. J Virol (1991) 2.65
Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol (2004) 2.59
Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation. Proc Natl Acad Sci U S A (1998) 2.50
The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J Virol (1989) 2.50
Human papillomavirus (HPV) in head and neck cancer. J Clin Virol (2005) 2.40
Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev (2006) 2.36
Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J Virol (1998) 2.35
Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene (2002) 2.34
Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res (2003) 2.32
Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev (1994) 2.32
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J (1999) 2.23
Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol (2006) 2.22
Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J Virol (1997) 2.21
Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene (2000) 2.20
Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virol (2003) 2.17
Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol (1996) 2.12
Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association. Mol Cell (2006) 2.11
The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem (1998) 2.07
The cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicase. Proc Natl Acad Sci U S A (1994) 2.04
The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol (1999) 2.01
Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc Natl Acad Sci U S A (1999) 2.00
Animal models of papillomavirus pathogenesis. Virus Res (2002) 1.98
Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol (2000) 1.97
Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J Virol (2006) 1.92
The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol (2003) 1.91
The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. Genes Dev (2004) 1.90
Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J Virol (2005) 1.87
The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J Virol (2005) 1.86
Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J Virol (2006) 1.81
The papillomavirus E1 protein forms a DNA-dependent hexameric complex with ATPase and DNA helicase activities. J Virol (1998) 1.77
HPV-associated skin disease. J Pathol (2006) 1.74
Interaction of the papillomavirus E2 protein with mitotic chromosomes. Virology (2000) 1.74
Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol (2007) 1.73
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene (2002) 1.71
Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol Cell (2006) 1.67
Biochemical and electron microscopic image analysis of the hexameric E1 helicase. J Biol Chem (1999) 1.66
The papillomavirus E2 proteins: structure, function, and biology. Annu Rev Biophys Biomol Struct (2001) 1.63
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res (1999) 1.63
Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc Natl Acad Sci U S A (1994) 1.62
Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA (2009) 1.60
Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J Virol (1997) 1.59
A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J Virol (1998) 1.59
Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication. Proc Natl Acad Sci U S A (1999) 1.59
Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci (2008) 1.59
Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J Virol (1997) 1.56
The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. EMBO J (1995) 1.50
Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. J Virol (1995) 1.48
Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology (2006) 1.47
RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol (2003) 1.47
Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J Virol (2006) 1.47
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother (1998) 1.47
Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol (2010) 1.45
Therapy for genital human papillomavirus-related disease. J Clin Virol (2005) 1.45
The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol (2004) 1.43
High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J Virol (1996) 1.42
Functional interactions between papillomavirus E1 and E2 proteins. J Virol (1997) 1.42
Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J Virol (1992) 1.41
Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc Natl Acad Sci U S A (1998) 1.41
Human papillomavirus DNA replication. Interactions between the viral E1 protein and two subunits of human dna polymerase alpha/primase. J Biol Chem (1999) 1.41
The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. J Virol (2007) 1.40
Recruitment and loading of the E1 initiator protein: an ATP-dependent process catalysed by a transcription factor. EMBO J (1998) 1.37
Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene (2007) 1.37
Interactions of the papovavirus DNA replication initiator proteins, bovine papillomavirus type 1 E1 and simian virus 40 large T antigen, with human replication protein A. J Virol (1999) 1.35
Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene (2011) 1.34
Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein. Proc Natl Acad Sci U S A (2005) 1.34
Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin Cancer Biol (2003) 1.32
cAMP response element-binding protein-binding protein binds to human papillomavirus E2 protein and activates E2-dependent transcription. J Biol Chem (2000) 1.28
Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells. J Virol (2005) 1.27
An unusual eukaryotic protein phosphatase required for transcription by RNA polymerase II and CTD dephosphorylation in S. cerevisiae. Mol Cell (1999) 2.14
Role of the ATP-binding domain of the human papillomavirus type 11 E1 helicase in E2-dependent binding to the origin. J Virol (1999) 1.56
In vitro characterization of mutant yeast RNA polymerase II with reduced binding for elongation factor TFIIS. Proc Natl Acad Sci U S A (1996) 1.27
Identification of domains of the human papillomavirus type 11 E1 helicase involved in oligomerization and binding to the viral origin. J Virol (2000) 1.22
A motif shared by TFIIF and TFIIB mediates their interaction with the RNA polymerase II carboxy-terminal domain phosphatase Fcp1p in Saccharomyces cerevisiae. Mol Cell Biol (2000) 1.18
Mechanical load stimulates expression of novel genes in vivo and in vitro in avian flexor tendon cells. Osteoarthritis Cartilage (1999) 1.10
Characterization of recombinant HPV6 and 11 E1 helicases: effect of ATP on the interaction of E1 with E2 and mapping of a minimal helicase domain. J Biol Chem (2001) 1.10
Identification of domains of the HPV11 E1 protein required for DNA replication in vitro. Virology (2000) 1.09
Characterization of the DNA-binding properties of the origin-binding domain of simian virus 40 large T antigen by fluorescence anisotropy. J Virol (2003) 1.05
Rpo26p, a subunit common to yeast RNA polymerases, is essential for the assembly of RNA polymerases I and II and for the stability of the largest subunits of these enzymes. Mol Cell Biol (1996) 0.90
Examining Dairy Products for Members of the Escherichia-Aerobacter Group. Am J Public Health Nations Health (1934) 0.85
Culture of insect cells in helical ribbon impeller bioreactor. Biotechnol Bioeng (1991) 0.83
Development of a helical-ribbon impeller bioreactor for high-density plant cell suspension culture. Biotechnol Bioeng (1992) 0.80
High-level recombinant protein production in bioreactors using the baculovirus-insect cell expression system. Biotechnol Bioeng (1990) 0.80
Detection of ginkgolide A in Ginkgo biloba cell cultures. Plant Cell Rep (1991) 0.77
Effect of polymeric adsorbents on the production of sanguinarine by Papaver somniferum cell cultures. Biotechnol Bioeng (1992) 0.77
Nutritional and hormonal requirements of Ginkgo biloba embryo-derived callus and suspension cell culture. Plant Cell Rep (1990) 0.76
Similar upstream regulatory elements of genes that encode the two largest subunits of RNA polymerase II in Saccharomyces cerevisiae. Nucleic Acids Res (1996) 0.75
Growth characteristics of Sanguinaria canadensis L. cell suspensions and immobilized cultures for production of benzophenanthridine alkaloids. Appl Microbiol Biotechnol (1992) 0.75
[Screening for scoliosis in schools. Study on 14,886 x-rays]. Union Med Can (1976) 0.75
Growth kinetics of vitis vinifera cell suspension cultures: I. Shake flask cultures. Biotechnol Bioeng (1995) 0.75
Surface immobilization of anchorage-dependent mammalian cells. Biotechnol Bioeng (1992) 0.75
Effect of culture process on alkaloid production by Catharanthus roseus cells. I. Suspension cultures. J Biotechnol (1991) 0.75
Non-medical use of drugs by students and alumni of Queen's University. Can J Public Health (1972) 0.75
Stimulated indole alkaloid release from Catharanthus roseus immobilized cultures. Initial studies. J Biotechnol (1991) 0.75
Effect of culture process on alkaloid production by Catharanthus roseus cells. II. Immobilized cultures. J Biotechnol (1991) 0.75
Formation of terpenoid products in Ginkgo biloba L. cultivated cells. Plant Cell Rep (1996) 0.75
[The surgical treatment of portal hypertension]. Laval Med (1965) 0.75
The Need of Uniformity of Conditions for Counting Plates-With a Suggestion for a Standard Colony Counter. Am J Public Health Nations Health (1937) 0.75
Oxygen transfer rates in a mammalian cell culture bioreactor equipped with a cell-lift impeller. Biotechnol Bioeng (1990) 0.75
[Central fractures of the acetabulum]. Union Med Can (1974) 0.75
Growth and immobilization of tripterygium wilfordii cultured cells. Biotechnol Bioeng (1991) 0.75
Dissolved Air as a Source of Error in Fermentation Tube Results. Am J Public Health Nations Health (1942) 0.75
The Need of Legislation and Social Service to Combat Syphilis in the Province of Quebec. Can Med Assoc J (1941) 0.75